Amanta Healthcare Limited (BOM:544502)

Market Cap	5.51B
Revenue (ttm)	2.88B +4.7%
Net Income	148.75M +41.7%
EPS	4.33 +16.7%
Shares Out	n/a
PE Ratio	37.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,846
Open	148.90
Previous Close	146.75
Day's Range	147.05 - 154.05
52-Week Range	93.10 - 164.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544502

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.88 billion, an increase of 4.72% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 22, 2026

Data Sources Report a data error